As a leader in in vitro drug evaluation, IPHASE is committed to delivering high-quality biological reagent solutions that support multiple areas of research, including in vitro pharmacokinetics (ADME), pharmacodynamics, toxicology (genetic toxicity), bioanalysis, and pathology (TCR). Our portfolio includes subcellular enzymes, primary cells, organoids, and biological tissues derived from both humans and experimental animals.
Leveraging advanced technologies such as cell sorting, we support cutting-edge research in Cell and Gene Therapy (CGT) and provide reliable tools that accelerate innovation throughout the drug development pipeline.
If you are attending BIOCHINA 2026, we would be delighted to connect, exchange insights, and explore collaboration opportunities. See you there!
Post time: 2026-03-11 11:00:21